UCB-Biopharma SRL, Early Solutions, Development Science, Non-Clinical Safety Evaluation, Braine L'Alleud, Belgium.
UCB-Biopharma SRL, Early Solutions, Development Science, Non-Clinical Safety Evaluation, Braine L'Alleud, Belgium.
J Pharmacol Toxicol Methods. 2023 Sep-Oct;123:107269. doi: 10.1016/j.vascn.2023.107269. Epub 2023 May 5.
This appraisal of state-of-the-art manuscript highlights and expands upon the thoughts conveyed in the lecture of Dr. Jean-Pierre Valentin, recipient of the 2021 Distinguished Service Award of the Safety Pharmacology Society, given on the 2nd December 2021. The article reflects on the strengths, weaknesses, opportunities, and threats that surrounded the evolution of safety and secondary pharmacology over the last 3 decades with a particular emphasis on pharmaceutical drug development delivery, scientific and technological innovation, complexities of regulatory framework and people leadership and development. The article further built on learnings from past experiences to tackle constantly emerging issues and evolving landscape whilst being cognizant of the challenges facing these disciplines in the broader drug development and societal context.
这篇最新文献述评突出并扩展了 2021 年安全药理学学会杰出服务奖获得者 Jean-Pierre Valentin 博士在 2021 年 12 月 2 日演讲中传达的思想。本文回顾了过去 30 年中安全药理学和次要药理学发展所面临的优势、劣势、机遇和威胁,特别强调了药物开发交付、科学技术创新、监管框架的复杂性以及人员领导和发展。本文进一步借鉴了过去的经验教训,以应对不断出现的问题和不断变化的格局,同时意识到这些学科在更广泛的药物开发和社会背景下面临的挑战。